8-K

CRH PUBLIC LTD CO 8-K Report (Apr 12, 2005)

Filed April 12, 2005For Securities:CRH

Summary

This 8-K filing from CRH Public Ltd Co, filed on April 12, 2005, primarily concerns notifications of director shareholding, specifically the grant of stock options to key personnel. Three directors—Thomas W. Hill, John L. Wittstock, and Myles Lee—along with Secretary Angela Malone, were granted options to purchase ordinary shares at a fixed price. These grants are part of the company's incentive programs and indicate continued investment and alignment of management interests with shareholders. The report details the number of shares covered by these new options, the exercise price, and the periods during which these options become exercisable. Investors can view this as a positive signal regarding management's commitment to the company's future performance, as significant option grants often imply an expectation of share price appreciation.

Key Highlights

  • 1Grant of stock options to Directors Thomas W. Hill, John L. Wittstock, and Myles Lee.
  • 2Secretary Angela Malone also received a grant of stock options.
  • 3Options were granted on April 11, 2005, and are exercisable between April 11, 2008, and April 10, 2015.
  • 4Thomas W. Hill was granted options for 35,000 ordinary shares at an exercise price of EUR 20.91.
  • 5John L. Wittstock was granted options for 35,000 ordinary shares at an exercise price of EUR 20.79.
  • 6Myles Lee was granted options for 50,000 ordinary shares at an exercise price of EUR 20.79.
  • 7Angela Malone was granted options for 4,300 ordinary shares at an exercise price of EUR 20.79.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report the granting of stock options to certain directors and the company secretary of CRH Public Ltd Co. This type of disclosure is required to inform investors about significant transactions involving company insiders.

The options were granted on April 11, 2005, and become exercisable between April 11, 2008, and April 10, 2015. The exercise prices range from EUR 20.79 to EUR 20.91 per ordinary share, with the number of shares granted varying for each individual.

For investors, the granting of stock options to directors and management typically signals confidence in the company's future prospects and an alignment of executive interests with shareholder value. It suggests that management believes the company's stock price will increase beyond the exercise price, offering a potential upside for both the executives and shareholders.

No, these options are not immediately exercisable. They have a vesting period, with the earliest date they can be exercised being April 11, 2008, and the latest date being April 10, 2015.